 Home > Active Ingredient News > Immunology News > The U.S. FDA approves the expansion of Ultomiris...

The U.S. FDA approves the expansion of Ultomiris...

 Last Update: 2021-06-20
 Source: Internet
 Author: User

Tags

sleep immune system

control system temperature

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Alexion Pharma recently announced that the U.

Ultomiris is a long-acting C5 complement inhibitor that can inhibit the C5 protein in the complement cascade of the human immune system, and can provide immediate, complete and sustained complement inhibition

Since it was first approved in 2018, Ultomiris has quickly become the standard treatment for adult patients with PNH in the United States

Ultomiris is designed to inhibit the C5 protein in the terminal part of the complement cascade, while retaining the functions of other parts of the immune system to resist common pathogens and infections

This approval is based on the results of a phase 3 clinical study

Note: The original text has been deleted

This article is from Bio Valley, for more information, please download the Bio Valley APP (http://

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

The U.S. FDA approves the expansion of the use of Ultomiris

06-16

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

The U.S. FDA approves the expansion of Ultomiris...

Related Articles

The U.S. FDA approves the expansion of the use of Ultomiris